|
🐜
|
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
45 auth.
A. Falsey,
M. Sobieszczyk,
I. Hirsch,
Stephanie Sproule,
M. Robb,
L. Corey,
K. Neuzil,
William W Hahn,
Julie Hunt,
M. Mulligan,
C. Mcevoy,
E. Dejesus,
Michael Hassman,
S. Little,
B. Pahud,
...
A. Durbin,
P. Pickrell,
E. Daar,
L. Bush,
Joel Solis,
Quito Osuna Carr,
Temitope Oyedele,
S. Buchbinder,
J. Cowden,
Sergio L Vargas,
Alfredo Guerreros Benavides,
R. Call,
M. Keefer,
B. Kirkpatrick,
J. Pullman,
T. Tong,
Margaret Brewinski Isaacs,
David C. Benkeser,
H. Janes,
M. Nason,
Justin A. Green,
E. Kelly,
Jill Maaske,
N. Mueller,
Kathryn Shoemaker,
Therese Takas,
Richard P. Marshall,
M. Pangalos,
T. Villafana,
Antonio Gonzalez-Lopez
|
8 |
2021 |
8
🐜
|
|
🐜
|
DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.
8 auth.
T. Blevins,
J. Pullman,
Jaret Malloy,
P. Yan,
K. Taylor,
Christine Schulteis,
...
M. Trautmann,
L. Porter
|
8 |
2011 |
8
🐜
|
|
🐜
|
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
7 auth.
R. DeFronzo,
R. Bergenstal,
W. Cefalu,
J. Pullman,
S. Lerman,
B. Bode,
...
L. Phillips
|
7 |
2005 |
7
🐜
|
|
🐜
|
Age-Dependent Neisseria meningitidis Serogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine
12 auth.
S. Maslanka,
J. Tappero,
B. Plikaytis,
R. Brumberg,
Janet K. Dykes,
L. Gheesling,
...
Kimberley B. J. Donaldson,
A. Schuchat,
J. Pullman,
Mark Jones,
Julie Bushmaker,
G. Carlone
|
6 |
1998 |
6
🐜
|
|
🐜
|
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
37 auth.
R. Vickers,
G. Tillotson,
S. Hazan,
B. Tejura,
D. Roblin,
D. Gerding,
M. Wilcox,
A. Bhan,
Wayne N. Campbell,
Teena Chopra,
K. Deck,
Y. Golan,
I. Gordon,
Ravi Kamepalli,
S. Khanna,
...
Christine H. Lee,
C. Lucasti,
B. Maliakkal,
Irene Minang,
K. Mullane,
Richard Nathan,
M. Oughton,
Y. Pesant,
J. Phillips,
J. Pullman,
P. Riska,
C. Schrock,
J. Siegel,
A. Steinberg,
D. Talan,
Stephen Tamang,
Michael Tan,
K. Weiss,
Chia C. Wang,
B. Yacyshyn,
Jo-Anne H. Young,
J. Zenilman
|
6 |
2017 |
6
🐜
|
|
🐜
|
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study
87 auth.
W. O'Riordan,
Alison J McManus,
J. Teras,
Ivan Poromanski,
Maria Cruz-Saldariagga,
M. Quintas,
L. Lawrence,
ShuJui Liang,
S. Cammarata,
G. Chaparro,
N. Frassone,
G. Morera,
Antônio Tarcisio de Faria Freire,
Julio Cesar Stobbe,
R. Dimov,
...
B. Ninov,
Ivan Poromanski,
P. Rusev,
S. Simeonov,
G. Todorov,
J. M. P. Godoy,
J. Lind,
A. Tein,
J. Teras,
A. Uksov,
Roland Akhalaia,
E. Gotsadze,
K. Kashibadze,
Jano Vashadze,
K. Egyud,
Z. Horváth,
L. Kemény,
Levente Kövágó,
Tibor Olah,
Y. Cho,
Seong-Ho Choi,
W. Choi,
Y. Chong,
M. J. Kim,
S. Kim,
Yeon-Sook Kim,
J. Gardovskis,
Viktors Lovcinovskis,
M. Nalivaiko,
G. Pupelis,
E. Noriega,
Nora Patricia Quintero Pérez,
A. Ortiz,
E. Guțu,
S. Revencu,
S. Ungureanu,
L. C. Cosavalente,
Jaime Ismael Soria Medina,
Maria Edelmira Cruz,
O. Reyna,
P. Leiva,
M. Ciurea,
I. Florea,
C. Giuglea,
S. Marinescu,
S. Morariu,
R. Orăsan,
P. Z. Crăiniceanu,
Yen-Hsu Chen,
Y. Chuang,
Sinikka Green,
Alison J McManus,
Jeffrey K Kingsley,
L. Miller,
R. Houghton,
V. L. Willits,
S. Mannis,
Sheri Stucke,
Peter Rives,
E. Hansen,
Pietro Giuseppe Pecci,
Hermilito L Villar,
R. Beasley,
P. Giordano,
J. Pullman,
Chok P. Wan,
S. Shah,
Godson Oguchi,
T. M. Birch,
S. Dar,
Barr Baynton,
Melanie Hoppers
|
6 |
2018 |
6
🐜
|
|
🐢
|
A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin
7 auth.
Jeffrey K Kingsley,
P. Mehra,
L. Lawrence,
E. Henry,
E. Duffy,
S. Cammarata,
...
J. Pullman
|
6 |
2015 |
6
🐢
|
|
🐜
|
MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.
10 auth.
A. Spec,
J. Pullman,
G. Thompson,
W. Powderly,
E. Tobin,
J. Vázquez,
...
S. Wring,
D. Angulo,
S. Helou,
P. Pappas
|
6 |
2019 |
6
🐜
|
|
🐜
|
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
10 auth.
M. Stryjewski,
A. Lentnek,
William O 'riordan,
J. Pullman,
P. Tambyah,
J. Miro,
...
V. Fowler,
S. Barriere,
M. Kitt,
Ralph Corey
|
6 |
2014 |
6
🐜
|
|
🦁
|
Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes
J. Pullman,
T. Darsow,
J. Frias
|
5 |
2006 |
5
🦁
|
